Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Case Of Mistaken Identity? South Korea Begins Sweep Of Unlicensed Salesmen Posing As Pharmacists

This article was originally published in PharmAsia News

Executive Summary

SEOUL - Days after the launch of the Korean version of the U.S. FDA's Consumer Safety Inspector, Korea FDA is moving to clamp down on the widespread practice of drugstores staffing unlicensed employees to sell drugs as pharmacists

You may also be interested in...



South Korea FDA Adds Teeth To Regs By Adding State Prosecutor To Safety Team

SEOUL - In an effort to increase compliance and give teeth to safety regulations, Korea FDA has begun to operate its version of U.S. FDA's Consumer Safety Inspector as it tries to counter illegal production and sales of what it calls "harmful" drugs, devices and food

Japan Clamps Down on Internet OTC Drug Sales

TOKYO - Most over-the-counter drugs available in Japan will no longer be available through parcel delivery service beginning June 1. Japan's Ministry of Health, Labor and Welfare defends its move saying consumers can more safely purchase OTC drugs when given face-to-face advice by pharmacists at drug stores

PharmAsia News Business Bulletin

A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).

UsernamePublicRestriction

Register

SC143367

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel